- Home
- PTGX vs LMAT Comparison
PTGX vs LMAT Comparison
Compare PTGX & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- LMAT
- Stock Information
- Founded
- PTGX 2006
- LMAT 1983
- Country
- PTGX United States
- LMAT United States
- Employees
- PTGX N/A
- LMAT N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- LMAT Medical/Dental Instruments
- Sector
- PTGX Health Care
- LMAT Health Care
- Exchange
- PTGX Nasdaq
- LMAT Nasdaq
- Market Cap
- PTGX 2.8B
- LMAT 2.0B
- IPO Year
- PTGX 2016
- LMAT 2006
- Fundamental
- Price
- PTGX $47.91
- LMAT $89.08
- Analyst Decision
- PTGX Strong Buy
- LMAT Buy
- Analyst Count
- PTGX 7
- LMAT 6
- Target Price
- PTGX $52.83
- LMAT $92.60
- AVG Volume (30 Days)
- PTGX 450.1K
- LMAT 98.3K
- Earning Date
- PTGX 11-08-2024
- LMAT 10-31-2024
- Dividend Yield
- PTGX N/A
- LMAT 0.72%
- EPS Growth
- PTGX N/A
- LMAT 47.83
- EPS
- PTGX 2.75
- LMAT 1.67
- Revenue
- PTGX $319,120,000.00
- LMAT $205,621,000.00
- Revenue This Year
- PTGX $400.33
- LMAT $15.01
- Revenue Next Year
- PTGX N/A
- LMAT $9.07
- P/E Ratio
- PTGX $17.54
- LMAT $54.11
- Revenue Growth
- PTGX 125.73
- LMAT 16.06
- 52 Week Low
- PTGX $13.76
- LMAT $45.96
- 52 Week High
- PTGX $48.89
- LMAT $93.32
- Technical
- Relative Strength Index (RSI)
- PTGX 60.40
- LMAT 55.00
- Support Level
- PTGX $45.33
- LMAT $84.69
- Resistance Level
- PTGX $48.89
- LMAT $92.84
- Average True Range (ATR)
- PTGX 1.28
- LMAT 2.05
- MACD
- PTGX 0.11
- LMAT -0.07
- Stochastic Oscillator
- PTGX 77.11
- LMAT 75.21
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About LMAT LeMaitre Vascular Inc.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.